| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.19 | 0.0008 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.2 | 0.001 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.19 | 0.002 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.18 | 0.002 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.22 | 0.002 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.17 | 0.004 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.005 |